FDA.reportPublic FDA data

Haegarda 3000 UNT Injection

RxCUI
1926827
RxNorm name
Haegarda 3000 UNT Injection
Display name
Haegarda 3000 UNT Injection
Full name
Haegarda 3000 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125606HaegardaC1 Esterase Inhibitor Subcutaneous (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e270ad38-adc4-4ed5-88e3-943b93d20a57HAEGARDA 3000 UNT Injection [PSN] · C1 esterase inhibitor (human) 3000 UNT Injection [Haegarda] [SBD] · Haegarda 3000 UNT Injection [SY]38These highlights do not include all the information needed to use HAEGARDA safely and effectively. See full prescribing information for HAEGARDA. HAEGARDA ® (C1 Esterase Inhibitor Subcutaneous [Human]) For Subcutaneous Injection, Freeze-Dried Powder for Reconstitution Initial U.S. Approval: 201720220204